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Inductive proteomics and large
dataset collections
Andrea Urbani,*ab Paola Roncada,c Alessandra Modesti,d Anna Maria Timperio,e
Luca Bini,f Mauro Fasanog and Massimo Castagnola*hi
In 1620 Francis Bacon published the
Novum Organum, opening a new era in
the experimental research of natural phe-
nomena based on the principle of induc-
tion. When describing this principle, he
anticipated the effects of advances in
science, engineering, and technology.
Such a principle opposed to the a priori
deductive knowledge has been the corner
stone for proteomics investigations based
on the unsupervised observation of pro-
tein modulation in a given biological
background. This approach has led to
contrasting evidence in the scientific lit-
erature from the last 20 years, primarily
based on the discoveries of unexpected
molecular association, to the complexity
of protein modulation and often to the
strong will of the investigators to poten-
tially extend the application of their
experimental observation beyond the
given experimental framework. A well-
known example of this experience is avail-
able in the quest for protein biomarker
discovery in clinical proteomics cam-
paigns. Unfortunately inductive methods
may only provide a probability for a given
argument in a well-defined framework
and their wide extension has been proved
by a number of philosophers, e.g. Karl
Popper and Bertrand Russell, to potentially
lead to false conclusions. Although the
introduction of a priori based proteomics
investigations by applying targeted SRM
(Selective Reaction Monitoring) design on
proteotypic transition brought a new
impulse, many researchers still prefer
inductive experimental methods in order
to obtain novel evidences. Inductive pro-
teomics still provides a passage through
the Pillars of Hercules, which for the
ancients, symbolized the limits of possible
human explorations. Beyond the pillars lay
the edge of current knowledge. Thus, their
crossing represents our aim toward new
uncharted biological molecular mechan-
isms. These open-platform investigations
are presently achieving a higher experi-
mental confidence, providing large dataset
collections for a more rigorous descrip-
tion of the experimental framework for
the application of the reported results.
In this themed issue dedicated to
proteomics we have a clear example of
such an extended description. The paper
from Claudia Desiderio et al., dedicated
to ‘Integrated proteomic platforms for
the comparative characterization ofmedul-
loblastoma and pilocytic astrocytoma
pediatric brain tumors’ (DOI: 10.1039/
C5MB00076A), provides a good example
of such a definition. Following the research
on medulloblastoma, Maurizio Ronci et al.
(DOI: 10.1039/C5MB00034C) addressed the
protein determinants associated with the
stemness phenotype in hedgehog models.
Glioblastoma response to nitric oxide
releasing compounds is addressed in the
paper by Roberta Leone et al. (DOI: 10.1039/
C4MB00725E) by applying 2DE-DIGE
approaches. Redox modifications of pro-
teins are further addressed in a well-
defined model for microglia exposure to
beta amyloid peptide in the work of Virginia
Correani et al. (DOI: 10.1039/C4MB00703D)
and in the paper by Claudia D’Anna et al.
(DOI: 10.1039/C5MB00188A) on the impact
of cigarette smoke on fibroblasts. While
clinical proteomics investigations based
on bottom-up approaches have been prov-
ing their limits, top-down proteomics
investigations represent a fundamental
approach to achieve the high specificity
required. The current FDA 510k and
CE-IVD approved proteomics-based plat-
forms for clinical microbiology (MALDI
Biotyper and Vitek MS) are in fact both
based on a top-down experimental set-up.
In this light, the work from Monica Sanna
et al. (DOI: 10.1039/C4MB00719K) may
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represent an initial step toward the defi-
nition of SAPHO syndrome molecular
markers in saliva. Integration of top-
down and bottom-up approaches is still
in its infancy. Nevertheless, the high
potentiality of such a strategy is provided
in the original paper of Domenico Milardi
et al. (DOI: 10.1039/C5MB00071H). Meta-
bolite profiling is becoming more and
more popular as an integrative strategy
in proteomics investigations. The
paper from Anna Maria Timperio et al.
(DOI: 10.1039/C4MB00660G) provides an
example in a yeast model. Overall, the
marriage of metabonomics investigations
in the field of proteomics is a common
leitmotif, as demonstrated by the contri-
butions from the groups of Margherita
Ruoppolo (DOI: 10.1039/C4MB00729H),
Piero Del Boccio (DOI: 10.1039/
C4MB00700J) and the review paper from
Stefania Orru`’s group (DOI: 10.1039/
C5MB00030K). Moreover, following the
activity of the Mitochondrial Human
Proteome Project initiative of the Italian
community, Antonio Lucacchini’s group
produced an interesting evaluation of the
metabolic reprogramming of themitochon-
drial proteome in a rat model of pancreatic
beta cells (DOI: 10.1039/C5MB00022J).
As guest-editors, we would like to
warmly thank all contributors to this
collection for making it such a success.
We hope the readers will enjoy the selec-
tion of papers in this year’s Proteomics
themed issue.
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